A pain-relieving topical ointment was recalled by the U.S. Consumer Product Safety Commission after they determined that the packaging was not child-resistant. The recall stated that the Mamisan brand ...

WASHINGTON, D.C. — More than 50,000 containers of a widely sold pain-relief ointment have been recalled after federal officials warned the packaging could put young children at risk of serious injury ...

· First MHRA-approved low-dose atropine eye drop to slow the progression of myopia (short-sightedness) in children aged 3-14 years with a progression rate of 0.5 D or more per year and a severity of ...

A Chinese woman shocked the internet after developing purplish-red “snake skin” patterns on her body from using a “pure traditional Chinese medicine” ointment for over a decade. The 40-year-old woman, ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...

Plenty of stars swear by Lanolips. Getty Images for The Met Museum/Vogue; Christopher Khoury/Australian Press Agency via ZUMA / SplashNews.com; Getty Images for Billboard; Lanolips Page Six may be ...

A Prescription Drug User Fee Act target date of October 23, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with those using placebo or 0.01% atropine, though they had higher rates of ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...